Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
19
KNW Quote, Financials, Valuation and Earnings
Last price:
$0.14
Seasonality move
:
24.87%
Day range:
$0.13 - $0.16
52-week range:
$0.13 - $0.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.4M
Avg. volume:
664.1K
1-year change:
-75.75%
Market cap:
$15.5M
Revenue:
--
EPS (TTM):
-$0.20
Analysts' Opinion
-
Consensus RatingKnow Labs has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Know Labs has an estimated upside of 598.81% from its current price of $0.14.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.14.
Fair Value
-
According to the consensus of 0 analysts, Know Labs has 598.81% upside to fair value with a price target of -- per share.
KNW vs. S&P 500
-
Over the past 5 trading days, Know Labs has underperformed the S&P 500 by -31.46% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Know Labs does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Know Labs revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Know Labs reported revenues of --.
Earnings Growth
-
Know Labs earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Know Labs reported earnings per share of -$0.04.
Enterprise value:
17.1M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
-1.32x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | $929.6K | -- | -- | -- | -- | |
| Operating Income | -$12.6M | -$14M | -$15.2M | -$2.3M | -$3.2M | |
| EBITDA | -$11.7M | -$14.5M | -$14.8M | -$2.8M | -$3.1M | |
| Diluted EPS | -$0.51 | -$0.41 | -$0.20 | -$0.05 | -$0.04 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Total Assets | $4.7M | $12.9M | $13.8M | $8.3M | $3.7M | |
| Current Liabilities | $6.3M | $11M | $3.8M | $4.5M | $5.2M | |
| Total Liabilities | $6.6M | $11.6M | $3.9M | $4.5M | $5.8M | |
| Total Equity | -$1.9M | $1.2M | $9.9M | $3.7M | -$2.2M | |
| Total Debt | $4.2M | $9.6M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.9M | -$10.4M | -$12.8M | -$1.4M | -$3.3M | |
| Cash From Investing | -$855.5K | -$80.8K | -$66.4K | -- | -- | |
| Cash From Financing | $8.1M | $5.9M | $8M | $5.5M | $4.2M | |
| Free Cash Flow | -$7.8M | -$10.4M | -$12.9M | -$1.4M | -$3.3M | |
KNW
Sector
Market Cap
$15.5M
$44.6M
Price % of 52-Week High
15.49%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
-75.75%
-29.09%
Beta (5-Year)
1.504
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.20
200-day SMA
Sell
Level
$0.42
Bollinger Bands (100)
Sell
Level
0.22 - 0.3
Chaikin Money Flow
Sell
Level
-1.8M
20-day SMA
Sell
Level
$0.22
Relative Strength Index (RSI14)
Sell
Level
27.55
ADX Line
Sell
Level
13.78
Williams %R
Buy
Level
-95.0566
50-day SMA
Sell
Level
$0.22
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Sell
Level
-44.6M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
Stock Forecast FAQ
In the current month, KNW has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KNW average analyst price target in the past 3 months is --.
-
Where Will Know Labs Stock Be In 1 Year?
According to analysts, the consensus estimate is that Know Labs share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Know Labs?
Analysts are divided on their view about Know Labs share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Know Labs is a Sell and believe this share price will drop from its current level to --.
-
What Is Know Labs's Price Target?
The price target for Know Labs over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is KNW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Know Labs is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KNW?
You can purchase shares of Know Labs via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Know Labs shares.
-
What Is The Know Labs Share Price Today?
Know Labs was last trading at $0.14 per share. This represents the most recent stock quote for Know Labs. Yesterday, Know Labs closed at $0.14 per share.
-
How To Buy Know Labs Stock Online?
In order to purchase Know Labs stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
